Patents by Inventor Shane Hoversten

Shane Hoversten has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260066137
    Abstract: Methods and systems for flowing a progression of an adverse health condition using reflection through a digital communication network (DCN) are provided. A DCN is provided for a plurality of members of a population to communicate with each other and communications from an individual member are analyzed. A time to transmit an automated communication to the individual member is determined and the automated communication is transmitted to the individual member at the determined time. The automated communication requests that the individual member respond indicating a current level of at least one of a psychological or physiological measurement. A response from the individual member is received through the DCN.
    Type: Application
    Filed: August 28, 2025
    Publication date: March 5, 2026
    Applicant: Sequelae, Inc.
    Inventors: Sara Taylor, Scott Archibald, Benjamin C. Wiegand, Shane Hoversten, Steven J. Catani
  • Patent number: 12539058
    Abstract: Embodiments include methods and systems for regulating a user's glucose levels. Systems comprise a processing unit in communication with a glucose monitor, an accelerometer, and a user interface. The glucose monitor generates glucose readings corresponding to the user's glucose levels and the accelerometer generates acceleration readings corresponding to the user's activity. The processing unit determines if the glucose readings indicate a glucose state and whether the acceleration readings indicate an activity state. If the glucose state and the activity state coincide, the processing unit sends a message to the user interface recommending a behavior that would influence the user's glucose level.
    Type: Grant
    Filed: November 12, 2021
    Date of Patent: February 3, 2026
    Assignee: Optum Labs, LLC
    Inventors: Kenneth S. Ehlert, Steven Catani, Shane Hoversten, Grant Brian Weller
  • Publication number: 20250356965
    Abstract: Systems and methods for inducing personal reflection in an individual member using a digital communication network (DCN) are provided. The DCN is provided to a plurality of members of a population to communicate with each other. The individual member is identified based on at least one communication in the DCN from the individual member that includes at least one observation. The communication is analyzed and at least one question is generated related to the observation. The at least one question is transmitted to the individual member.
    Type: Application
    Filed: May 14, 2025
    Publication date: November 20, 2025
    Applicant: Sequelae, Inc.
    Inventors: Natalie Sheils, Danielle Marria Martin, Rathish Mohan, Sara Taylor, Shane Hoversten, Benjamin C. Wiegand, Steven J. Catani
  • Publication number: 20250299839
    Abstract: Systems and methods for supporting health-based communications are provided. A digital communication network (DCN) for a plurality of members of a population to interact with each other and the DCN is provided. An invitation is transmitted to an individual member of the plurality of members to test a biological marker related to the adverse health condition and instructions are provided to the individual member to test the biological marker. A test result of the biological marker is received through the DCN and the individual member is enabled to share the test result with other members of the plurality of members through the DCN.
    Type: Application
    Filed: March 19, 2025
    Publication date: September 25, 2025
    Applicant: Sequelae, Inc.
    Inventors: James LaBelle, Sara Taylor, John Michael Gray, Shane Hoversten, Mark Briesacher, Steven J. Catani
  • Patent number: 11185260
    Abstract: Embodiments include methods and systems for regulating a user's glucose levels. Systems comprise a processing unit in communication with a glucose monitor, an accelerometer, and a user interface. The glucose monitor generates glucose readings corresponding to the user's glucose levels and the accelerometer generates acceleration readings corresponding to the user's activity. The processing unit determines if the glucose readings indicate a glucose state and whether the acceleration readings indicate an activity state. If the glucose state and the activity state coincide, the processing unit sends a message to the user interface recommending a behavior that would influence the user's glucose level.
    Type: Grant
    Filed: August 14, 2018
    Date of Patent: November 30, 2021
    Assignee: Optum Labs, LLC
    Inventors: Kenneth S Ehlert, Steven Catani, Shane Hoversten, Grant Brian Weller